miRNA description for hsa-miR-1827
miRNA accession hsa-miR-1827
Species Homo sapiens
 hsa-miR-1827 identified in sEVs derived from the following tissue/cell type
Colorectal cancer cells 34887515    
Plasma 36455873    
 Experiment description of studies that identified hsa-miR-1827 in sEVs
1
Experiment ID 1203
Identified molecule miRNA
Identification method
RNA sequencing   
PubMed ID 34887515    
Organism Homo sapiens
Experiment description Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets
Authors "Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ."
Journal name Nat Cell Biol
Publication year 2021
Sample Colorectal cancer cells
Sample name DiFi
Molecules identified in the study Protein
miRNA
Methods used in the study Western blotting
Mass spectrometry
RNA sequencing
2
Experiment ID 537
Identified molecule miRNA
Identification method
RNA sequencing   
PubMed ID 36455873    
Organism Homo sapiens
Experiment description Sevoflurane-induced POCD-associated exosomes delivered miR-584-5p regulates the growth of human microglia HMC3 cells through targeting BDNF
Authors "Zhao J, Zhang W, Wang S, Li Z, Huang Y, Li L."
Journal name Aging
Publication year 2022
Sample Plasma
Sample name Patients without post-operative cognitive dysfunction (non-POCD)
Molecules identified in the study Protein
miRNA
Methods used in the study Western blotting
Small RNA sequencing
RT-qPCR